Central University of Finance and Economics
Beijing, Beijing Municipality, 100875, China
NCT Number: NCT06658431
The purpose of this trial is to understand whether a mindfulness-integrated volleyball team sports program can effectively intervene in the mental health of college students. The main questions it aims to answer is:
Does the music group effectively intervene in the participants' mental health levels, including indicators such as anxiety and depression?
Participants will:
Attend a music group once a week for 1.5 hours each session, for a total of 6 weeks.
Complete a psychological questionnaire every 3 weeks and a follow-up questionnaire every 2 weeks after the program concludes for twice.
This study is active but is not currently recruiting participants.
Notify Me16 year and older
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100875, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
90 minutes music group therapy
Time frame: From enrollment to 4 weeks after the end of treatment.
Using GAD-7 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end), and T5 (4 weeks after the end).
Time frame: From enrollment to 4 weeks after the end of treatment.
Using PHQ-9 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
Time frame: From enrollment to 4 weeks after the end of treatment.
Using PSS-10 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
Time frame: From enrollment to 4 weeks after the end of treatment.
Using ISI-7 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
Time frame: From enrollment to 4 weeks after the end of treatment.
Using PANAS-10 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
Time frame: From enrollment to 4 weeks after the end of treatment.
Using SWLS-5 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
Time frame: From enrollment to 4 weeks after the end of treatment.
Using MBI-SS-15 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
Time frame: From enrollment to 4 weeks after the end of treatment.
Using ERQ-10 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
Time frame: From enrollment to 4 weeks after the end of treatment.
Using UCLA Scale to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
Time frame: From enrollment to 4 weeks after the end of treatment.
Using SAQ-16 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
Time frame: From enrollment to 4 weeks after the end of treatment.
Using MSPSS-6 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
Ye Zhiyin
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07399314
Behavior, Depression Anxiety Disorder
Islamabad, Punjab Province, Pakistan
View Trial DetailsNCT07721753
Breast Cancer Survivors, Depression Anxiety Disorder
Xinxiang, Henan, China
View Trial DetailsNCT07716657
Depression Anxiety Disorder, Self-Criticism
São Cristóvão, Sergipe, Brazil
View Trial DetailsNCT07558772
Anxiety, Anxiety Disorders
Beijing, Beijing Municipality, China
View Trial Details